Newsroom

We wanted to start 2022 by reinforcing NeoGenomics Laboratories, Inc.’s promise to work toward state-of-the-art diagnostic and oncology testing for patients.

The proprietary, high sensitivity Sanger sequencing assay (LOD <1%), developed by NeoGenomics, was used in certain BeiGene Phase 2 and Phase 3 clinical studies to determine the MYD88 status of p

In the middle of the pandemic, GO2 Foundation for Lung Cancer appointed Dr. Jennifer King as their Chief Scientific Officer in May 2020.

Approximately every 2 minutes, a woman in the U.S. is diagnosed with breast cancer1. This high prevalence has led to rigorous standards of practice, from diagnosis to treatment.

Madhushree Ghosh

Precision medicine reduces unnecessary risks to patients including hazardous side effects as well as ineffective treatments (“trial and error” medicine).

We often hear “Don’t take anything personally”. However, that is not the case in terms of precision medicine. In 2015, the U.S. government launched the "Precision Medicine Initiative".

As a premier reference lab and global pharma services organization that runs over a million oncology tests annually, NeoGenomics Laboratories, Inc.